Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester?

Vincenzo Berghella, Witoon Prasertcharoensuk, Amanda Cotter, Juha Rasanen, Suneeta Mittal, Surasith Chaithongwongwatthana, Ricardo Gomez, Etaoin Kearney, Jorge Tolosa, Leonardo Pereira

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We sought to estimate the effect of indomethacin on duration of pregnancy in women with dilated cervix between 14 0/7 to 25 6/7 weeks. Demographics, risk factors, and outcomes were compared in women 14 6/7 to 25 6/7 weeks with a dilated cervix ≥ 1 cm who received indomethacin versus no indomethacin therapy, stratified for cerclage. Primary outcome was interval from presentation until delivery. Of 222 singleton gestations, 68 (31%) received indomethacin. In unadjusted and adjusted analyses, no significant differences were observed in interval from presentation to delivery and preterm birth <28, <32, or <35 weeks comparing the indomethacin and no indomethacin groups, even after stratification for cerclage. In multivariate logistic regression analysis limited to women receiving cerclage, preterm birth <32 weeks (odds ratio 0.56, 95% confidence interval 0.26, 1.25) and <35 weeks (odds ratio 0.52, 95% confidence interval 0.23, 1.14) suggested a possible but not significant benefit for indomethacin use. Indomethacin therapy in women with dilated cervix at 14 0/7 to 25 6/7 weeks, regardless of cerclage or not, had no effect on pregnancy outcomes.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalAmerican Journal of Perinatology
Volume26
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

First Labor Stage
Premature Birth
Second Pregnancy Trimester
Indomethacin
Cervix Uteri
Odds Ratio
Confidence Intervals
Pregnancy
Pregnancy Outcome
Logistic Models
Regression Analysis
Demography

Keywords

  • Cerclage
  • Cervical dilatation
  • Indomethacin
  • Preterm labor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Berghella, V., Prasertcharoensuk, W., Cotter, A., Rasanen, J., Mittal, S., Chaithongwongwatthana, S., ... Pereira, L. (2009). Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester? American Journal of Perinatology, 26(1), 13-20. https://doi.org/10.1055/s-0028-1091398

Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester? / Berghella, Vincenzo; Prasertcharoensuk, Witoon; Cotter, Amanda; Rasanen, Juha; Mittal, Suneeta; Chaithongwongwatthana, Surasith; Gomez, Ricardo; Kearney, Etaoin; Tolosa, Jorge; Pereira, Leonardo.

In: American Journal of Perinatology, Vol. 26, No. 1, 01.2009, p. 13-20.

Research output: Contribution to journalArticle

Berghella, V, Prasertcharoensuk, W, Cotter, A, Rasanen, J, Mittal, S, Chaithongwongwatthana, S, Gomez, R, Kearney, E, Tolosa, J & Pereira, L 2009, 'Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester?', American Journal of Perinatology, vol. 26, no. 1, pp. 13-20. https://doi.org/10.1055/s-0028-1091398
Berghella V, Prasertcharoensuk W, Cotter A, Rasanen J, Mittal S, Chaithongwongwatthana S et al. Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester? American Journal of Perinatology. 2009 Jan;26(1):13-20. https://doi.org/10.1055/s-0028-1091398
Berghella, Vincenzo ; Prasertcharoensuk, Witoon ; Cotter, Amanda ; Rasanen, Juha ; Mittal, Suneeta ; Chaithongwongwatthana, Surasith ; Gomez, Ricardo ; Kearney, Etaoin ; Tolosa, Jorge ; Pereira, Leonardo. / Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester?. In: American Journal of Perinatology. 2009 ; Vol. 26, No. 1. pp. 13-20.
@article{0f30f5a78b154a95af3d37d0353d3834,
title = "Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester?",
abstract = "We sought to estimate the effect of indomethacin on duration of pregnancy in women with dilated cervix between 14 0/7 to 25 6/7 weeks. Demographics, risk factors, and outcomes were compared in women 14 6/7 to 25 6/7 weeks with a dilated cervix ≥ 1 cm who received indomethacin versus no indomethacin therapy, stratified for cerclage. Primary outcome was interval from presentation until delivery. Of 222 singleton gestations, 68 (31{\%}) received indomethacin. In unadjusted and adjusted analyses, no significant differences were observed in interval from presentation to delivery and preterm birth <28, <32, or <35 weeks comparing the indomethacin and no indomethacin groups, even after stratification for cerclage. In multivariate logistic regression analysis limited to women receiving cerclage, preterm birth <32 weeks (odds ratio 0.56, 95{\%} confidence interval 0.26, 1.25) and <35 weeks (odds ratio 0.52, 95{\%} confidence interval 0.23, 1.14) suggested a possible but not significant benefit for indomethacin use. Indomethacin therapy in women with dilated cervix at 14 0/7 to 25 6/7 weeks, regardless of cerclage or not, had no effect on pregnancy outcomes.",
keywords = "Cerclage, Cervical dilatation, Indomethacin, Preterm labor",
author = "Vincenzo Berghella and Witoon Prasertcharoensuk and Amanda Cotter and Juha Rasanen and Suneeta Mittal and Surasith Chaithongwongwatthana and Ricardo Gomez and Etaoin Kearney and Jorge Tolosa and Leonardo Pereira",
year = "2009",
month = "1",
doi = "10.1055/s-0028-1091398",
language = "English (US)",
volume = "26",
pages = "13--20",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester?

AU - Berghella, Vincenzo

AU - Prasertcharoensuk, Witoon

AU - Cotter, Amanda

AU - Rasanen, Juha

AU - Mittal, Suneeta

AU - Chaithongwongwatthana, Surasith

AU - Gomez, Ricardo

AU - Kearney, Etaoin

AU - Tolosa, Jorge

AU - Pereira, Leonardo

PY - 2009/1

Y1 - 2009/1

N2 - We sought to estimate the effect of indomethacin on duration of pregnancy in women with dilated cervix between 14 0/7 to 25 6/7 weeks. Demographics, risk factors, and outcomes were compared in women 14 6/7 to 25 6/7 weeks with a dilated cervix ≥ 1 cm who received indomethacin versus no indomethacin therapy, stratified for cerclage. Primary outcome was interval from presentation until delivery. Of 222 singleton gestations, 68 (31%) received indomethacin. In unadjusted and adjusted analyses, no significant differences were observed in interval from presentation to delivery and preterm birth <28, <32, or <35 weeks comparing the indomethacin and no indomethacin groups, even after stratification for cerclage. In multivariate logistic regression analysis limited to women receiving cerclage, preterm birth <32 weeks (odds ratio 0.56, 95% confidence interval 0.26, 1.25) and <35 weeks (odds ratio 0.52, 95% confidence interval 0.23, 1.14) suggested a possible but not significant benefit for indomethacin use. Indomethacin therapy in women with dilated cervix at 14 0/7 to 25 6/7 weeks, regardless of cerclage or not, had no effect on pregnancy outcomes.

AB - We sought to estimate the effect of indomethacin on duration of pregnancy in women with dilated cervix between 14 0/7 to 25 6/7 weeks. Demographics, risk factors, and outcomes were compared in women 14 6/7 to 25 6/7 weeks with a dilated cervix ≥ 1 cm who received indomethacin versus no indomethacin therapy, stratified for cerclage. Primary outcome was interval from presentation until delivery. Of 222 singleton gestations, 68 (31%) received indomethacin. In unadjusted and adjusted analyses, no significant differences were observed in interval from presentation to delivery and preterm birth <28, <32, or <35 weeks comparing the indomethacin and no indomethacin groups, even after stratification for cerclage. In multivariate logistic regression analysis limited to women receiving cerclage, preterm birth <32 weeks (odds ratio 0.56, 95% confidence interval 0.26, 1.25) and <35 weeks (odds ratio 0.52, 95% confidence interval 0.23, 1.14) suggested a possible but not significant benefit for indomethacin use. Indomethacin therapy in women with dilated cervix at 14 0/7 to 25 6/7 weeks, regardless of cerclage or not, had no effect on pregnancy outcomes.

KW - Cerclage

KW - Cervical dilatation

KW - Indomethacin

KW - Preterm labor

UR - http://www.scopus.com/inward/record.url?scp=58349100508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349100508&partnerID=8YFLogxK

U2 - 10.1055/s-0028-1091398

DO - 10.1055/s-0028-1091398

M3 - Article

VL - 26

SP - 13

EP - 20

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 1

ER -